31 – 40 of 105
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment
(
- Contribution to journal › Article
-
Mark
Genetic Risk Prediction of Atrial Fibrillation
(
- Contribution to journal › Article
-
Mark
Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) and Impaired Kidney Function in the Population-based Malmö Diet and Cancer Study
(
- Contribution to journal › Article
-
Mark
High Level of Fasting Plasma Proenkephalin-A Predicts Deterioration of Kidney Function and Incidence of CKD
(
- Contribution to journal › Article
-
Mark
Utilization of genetic data can improve the prediction of type 2 diabetes incidence in a Swedish cohort
(
- Contribution to journal › Article
-
Mark
Elevated Markers of Death Receptor-Activated Apoptosis are Associated with Increased Risk for Development of Diabetes and Cardiovascular Disease
(
- Contribution to journal › Article
-
Mark
Genetic determinants of circulating GIP and GLP-1 concentrations
(
- Contribution to journal › Article
-
Mark
Genetic determinants of growth hormone and GH-related phenotypes
(
- Contribution to journal › Article
-
Mark
Plasma stem cell factor levels are associated with risk of cardiovascular disease and death
(
- Contribution to journal › Article
-
Mark
An Expanded Genome-Wide Association Study of Type 2 Diabetes in Europeans
(
- Contribution to journal › Article